Back to results
US 2010/0303718 A1Published application
Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials
AssigneeLyotropic Therapeutics, Inc.
InventorDavid Anderson
Life of this patent
Estimating the term…
Abstract
Uncoated particles of reversed cubic phase or reversed hexagonal phase material containing an active disposed within are provided. The uncoated particles have an ionic charge that is sufficient to stabilize them in dispersion in a liquid, e.g. a polar solvent. The active that is disposed within the particles may be, for example, a pharmaceutical or nutriceutical compound.
Claims62
1-200. (canceled)
A composition pharmaceutically acceptable for injection in a mammal, comprising:
- (i) a plurality of uncoated, ionically charged particles comprising reversed cubic phase or reversed hexagonal phase material which includes at least one charged, bilayer associated ingredient wherein a total of all charged, bilayer associated ingredients in the reversed cubic phase or reversed hexagonal phase material is between 0.02:1 and 0.08:1, and
- (ii) a liquid comprising a polar solvent,
- said uncoated, ionically charged particles being stabilized in dispersion in said liquid, and
- said uncoated, ionically charged particles have a size of from 40 nm to 10 microns.
1 more element
The composition of claim 202 wherein said reversed cubic phase or reversed hexagonal phase material comprises phosphatidylcholine.
Dependencies are inferred from the claim text.